Propofol

Generic Name
Propofol
Brand Names
Diprivan
Drug Type
Small Molecule
Chemical Formula
C12H18O
CAS Number
2078-54-8
Unique Ingredient Identifier
YI7VU623SF
Background

Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. ...

Indication

Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.

Associated Conditions
-
Associated Therapies
Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy
Clinical Trials
Related News

Effect of Remimazolam on Postoperative Delirium

First Posted Date
2023-12-26
Last Posted Date
2023-12-26
Lead Sponsor
Zhihong LU
Target Recruit Count
190
Registration Number
NCT06180876
Locations
🇨🇳

Xijing hospital, Fourth military medical university, Xi'an, Shaanxi, China

EEG-fMRI Experiments During Anesthesia Induction With Propofol

First Posted Date
2023-12-22
Last Posted Date
2023-12-22
Lead Sponsor
Technical University of Munich
Target Recruit Count
35
Registration Number
NCT06179719
Locations
🇩🇪

Klinikum rechts der Isar - Klinik für Anästhesiologie und Intensivmedizin, Munich, Bavaria, Germany

🇩🇪

Technische Universität München, München, München (Stadt), Germany

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

Not Applicable
Recruiting
Conditions
Liver Cancer
Ciprofol
Interventions
Drug: Propofol
Drug: Ciprofol
First Posted Date
2023-12-21
Last Posted Date
2023-12-21
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
80
Registration Number
NCT06178926
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma

First Posted Date
2023-11-18
Last Posted Date
2023-11-18
Lead Sponsor
Beijing Tiantan Hospital
Target Recruit Count
120
Registration Number
NCT06138340
Locations
🇨🇳

Beijing Tian Tan Hospital, Capital Medical University, Beijing, Beijing, China

Magnesium Sulfate as an Adjuvant to Propofol During Consious Sedation in Colonoscopy

Phase 2
Not yet recruiting
Conditions
Intraoperative Analgesia
Magnesium
Interventions
Drug: Propofol
Drug: Magnesium Sulfate
First Posted Date
2023-11-14
Last Posted Date
2023-12-18
Lead Sponsor
Assiut University
Target Recruit Count
60
Registration Number
NCT06131905

Comparison of Procedural Sedation in TEE

Phase 1
Not yet recruiting
Conditions
Anesthesia
Interventions
Drug: Remimazolam
Drug: Propofol
First Posted Date
2023-11-13
Last Posted Date
2024-10-10
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
120
Registration Number
NCT06129188

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

Not Applicable
Recruiting
Conditions
Postoperative Delirium
Interventions
Drug: Remimazolam
Drug: Propofol
First Posted Date
2023-11-02
Last Posted Date
2024-04-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
696
Registration Number
NCT06115031
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Dexmedetomidine and Propofol in Mechanically Ventilated Patients by Using Salivary Alpha-amylase as a Stress Marker

First Posted Date
2023-10-24
Last Posted Date
2024-05-14
Lead Sponsor
Tanta University
Target Recruit Count
40
Registration Number
NCT06098209
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

Not Applicable
Completed
Conditions
Prostate Tumor
Interventions
Drug: remimazolam
Drug: Propofol
First Posted Date
2023-10-23
Last Posted Date
2024-12-12
Lead Sponsor
Yonsei University
Target Recruit Count
112
Registration Number
NCT06093971
Locations
🇰🇷

Yonsei University College of Medicine, Seoul, Korea, Republic of

Etomidate Versus Propofol in CABG Surgery

Phase 4
Recruiting
Conditions
Coronary Artery Disease
Interventions
Drug: Propofol
Drug: Etomidate
First Posted Date
2023-10-05
Last Posted Date
2023-12-28
Lead Sponsor
Hartford Hospital
Target Recruit Count
300
Registration Number
NCT06068764
Locations
🇺🇸

Hartford Hospital, Hartford, Connecticut, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy